Recruiting

Observational Study

Sponsor:

Massachusetts General Hospital

Code:

NCT02321735

Conditions

Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Quality of life questionaire

Study Details

Brief summary:

: Stages III and IV serum ovarian cancer are the most lethal of all gynecologic cancers; however, some advanced-stage ovarian cancer patients are long-term survivors. These patients may provide the key to long-term survival and bring hope to all women with Stages III and IV ovarian cancer. There is no meaningful explanation of why some patients with ovarian cancer become long-term survivors and what their quality of life is long after their initial diagnosis. This research project will specifically determine molecular features within tumors along with genetic, quality of life, and lifestyle features that predict for long-term survival for patients with Stages III and IV ovarian cancer. It will bring together sophisticated molecular techniques, researchers with longstanding interest, a wide spectrum of consumer advocates (a number being long-term survivors), and quality of life experts to analyze the most carefully maintained patient database in the world-the Gynecologic Oncology Group database. We anticipate the results from this project will identify specific biochemical pathways and genetic features associated with long-term survival that can be used to improve the treatment, survival, and survivorship of patients with this disease. There is clearly something unique among patients who survive Stage III or IV ovarian cancer long term, and we believe that when we understand what this is, we can increase the number of long- and longer-term survivors.

Conditions

Ovarian Cancer

Study ID

NCT02321735

Start date

Sep, 2014

Status verified date

Mar, 2016

Completion date

Sep, 2019

Anticipated

Primary completion date

Sep, 2019

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • stage III/IV high grade epithelial ovarian cancer diagnosed at least 10 years ago

Exclusion Criteria:

  • early stage, low grade ovarian cancer diagnosed less than 10 years ago

Study Design

Enrollment

400 participants

Anticipated

Intervention Model

Single group

Interventions and Outcome Measures

Arms

other: Long-Term Ovarian Cancer survivors

Genomic, immunologic and psychosocial characterization of Long-Term survivors of ovarian cancer. This will involve a Quality of Life Questionaire.

Interventions

Quality of life questionaire

Patients will participate in a QOL questionaire followed by a phone interview

Primary outcome measure

  • Quality of life questionnaire [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Locations

Massachusetts General Hospital (The General Hospital Corp)

Recruiting

Boston, Massachusetts, United States, 02114

Contacts

More Information

Sponsor

Massachusetts General Hospital

Last update posted

Mar 17, 2016

Last verified

Mar, 2016

Keywords

  • Long-Term Survivor
  • Genomic
  • Survivorship
  • Quality of Life

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2016-03-17.